Taysha Gene Therapies
TSHA
#5807
Rank
S$1.58 B
Marketcap
S$4.87
Share price
-5.51%
Change (1 day)
-6.69%
Change (1 year)

EPS for Taysha Gene Therapies (TSHA)

EPS in 2026 (TTM): S-$0.55

According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is S-$0.56. In 2022 the company made an earnings per share (EPS) of S-$4.92 an increase over its 2021 EPS that were of S-$5.98.

EPS history for Taysha Gene Therapies from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.55
2022S-$4.92-17.71%
2021S-$5.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
S-$1.74 213.95%๐Ÿ‡บ๐Ÿ‡ธ USA